UNONA Holdings

Unona is a prominent Russian medical and pharmaceutical holding company headquartered in Yekaterinburg. The group operates a vertically integrated business model, encompassing the research, development, and manufacturing of pharmaceutical products and medical devices. Its flagship subsidiary, Medsintez Plant, is a major producer of genetically engineered human insulin under the brand Rosinsulin and the proprietary antiviral drug Triazavirin. Beyond pharmaceuticals, Unona is a significant player in the nephrology sector, manufacturing hemodialysis equipment and consumables. The company also operates a network of specialized dialysis clinics to provide comprehensive care for patients with chronic kidney disease. Through its various subsidiaries, Unona integrates scientific research with industrial-scale production to address critical healthcare needs.